Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06295757 · ClinicalTrials.gov registry record · NA
Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
A NA study of Tobacco Use and Nicotine Dependence, sponsored by Masonic Cancer Center, University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06295757: Recruiting NA study of Tobacco Use and Nicotine Dependence, sponsored by Masonic Cancer Center, University of Minnesota.
NCT06295757 is a NA study of Tobacco Use and Nicotine Dependence that is actively recruiting participants, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 30 participants, below the 379-participant average among 76 other Tobacco Use trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06295757, a NA study of Tobacco Use and Nicotine Dependence, is actively recruiting participants, sponsored by Masonic Cancer Center, University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Characterize effects of relighting on smoke toxicant deliveries and subjective smoking measures. This will be a within-subject comparison in a single experimental group of 30 smokers who report engaging in relighting behaviors. We will assess smoking intensity for relit and non-relit (i.e., smoked continuously without relighting) cigarettes in the natural environment and will conduct in-clinic measurements of smoking topography and subjective responses for relit and non-relit cigarettes. Information on relighting patterns and smoking topography collected from each participant will be used to compare machine-measured smoke yields of key harmful constituents when their usual cigarettes are smoked with and without relighting. Hypothesis: Relit cigarettes will produce higher levels of toxicants than non-relit cigarettes.
Primary Outcome
Level of nicotine in cigarette butts collected during study.
Conditions Studied
Interventions
- OTHER Cigarettes
Study Locations (1)
Minnesota
- Irina Stepanov, PhD - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-10-12 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
What NCT06295757 shows while recruiting
NCT06295757 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 379-participant average among 76 other Tobacco Use trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Tobacco Use appearing as the primary indexed condition, and to 1 intervention - of which Cigarettes is the first listed.
NCT06295757 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06295757 about?
NCT06295757 is a clinical study titled "Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures". Characterize effects of relighting on smoke toxicant deliveries and subjective smoking measures. This will be a within-subject comparison in a single experimental group of 30 smokers who report engaging in relighting behaviors. We will assess smoking intensity for relit and non-relit (i.e., smoked c...
What is the current status of trial NCT06295757?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-10-12. Estimated completion is 2028-01-01.
What conditions does trial NCT06295757 study?
This clinical trial studies the following conditions: Tobacco Use, Nicotine Dependence, Cigarette Smoking.
What interventions are being tested in trial NCT06295757?
The interventions under investigation include: Cigarettes (OTHER).
Who is sponsoring clinical trial NCT06295757?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06295757 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06295757's enrollment target sits among peer trials
30 68th of 76 higher than 9 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI